Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LEVONORGESTREL

LEVONORGESTREL

Standard Dose
0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview LEVONORGESTREL is listed in Drugs@FDA under application 078665 (ANDA).

Marketing status: Discontinued Active ingredient LEVONORGESTREL Form and strength TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FDN CONSUMER Submission history Latest submission status date: 2012-09-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVONORGESTREL is listed in Drugs@FDA under application 078665 (ANDA). Marketing status: Discontinued Active ingredient LEVONORGESTREL Form and strength TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FDN CONSUMER Submission history Latest submission status date: 2012-09-26 00:00:00. Submission type: SUPPL.

Monitoring

  • Review priority: STANDARD
  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
LEVONORGESTREL (LEVONORGESTREL) | Drug Monograph | MedicHelpline